Ignite Creation Date:
2025-12-24 @ 6:37 PM
Ignite Modification Date:
2026-04-05 @ 9:43 PM
Study NCT ID:
NCT00887757
Status:
COMPLETED
Last Update Posted:
2017-11-21
First Post:
2009-04-23
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety Study of ABT-263 in Combination With Gemzar (Gemcitabine) in Subjects With Solid Tumors
Sponsor:
AbbVie
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-09
Start Date Type:
None
Primary Completion Date:
2011-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2011-11
Completion Date Type:
ACTUAL
First Submit Date:
2009-04-23
First Submit QC Date:
None
Study First Post Date:
2009-04-24
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-11-17
Last Update Post Date:
2017-11-21
Last Update Post Date Type:
ACTUAL